Israel Englander Puma Biotechnology, Inc. Transaction History
Millennium Management LLC
- $199 Billion
- Q3 2024
A detailed history of Israel Englander (Millennium Management LLC) transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 2,880,888 shares of PBYI stock, worth $8.1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,880,888
Previous 3,162,533
8.91%
Holding current value
$8.1 Million
Previous $10.3 Million
28.74%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding PBYI
# of Institutions
101Shares Held
29MCall Options Held
50.6KPut Options Held
16.3K-
Vanguard Group Inc Valley Forge, PA3.64MShares$10.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.57MShares$10 Million0.0% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.06MShares$8.61 Million0.42% of portfolio
-
Acadian Asset Management LLC Boston, MA1.97MShares$5.53 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.77MShares$4.98 Million0.01% of portfolio
About PUMA BIOTECHNOLOGY, INC.
- Ticker PBYI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,556,000
- Market Cap $128M
- Description
- Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...